- Home
- / Anterogen
Anterogen
Stock Price
₩15 K
2024-10-29
Market Capitalization
₩146 B
2024-10-29
Revenue
₩7.5 B
FY, 2025
Anterogen Summary
Company Summary
- Overview
- Anterogen is a biotech company that researches and develops cell therapy products and drugs using adult stem cells. Its products include Cupistem, Adipocell, Queencell, etc.
- Type
- Public
- Status
- Active
- Founded
- 2000
- HQ
- KR | view all locations
- Website
- http://www.anterogen.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Seoul HQ
Korea (Republic of)
345-30 Gasan-dong, Geumcheon-gu
Anterogen Financials
Summary Financials
- Revenue (FY, 2025)
- ₩7.5B
- Gross profit (FY, 2025)
- ₩3.0B
- Net income (FY, 2025)
- (₩1.4B)
- Cash (FY, 2025)
- ₩1.6B
- EBIT (FY, 2025)
- (₩2.4B)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026